The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Nov. 19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skincancer and describes their different immunomodulatory roles in the tumor ...